Halozyme Therapeutics

Torley
Favicon Fierce Pharma

Halozyme CEO targets new deals as IRA uncertainty subsides

As drug developers gain a better grasp of the IRA’s impact, Halozyme has seen a ramp-up in deal discussions over its subcutaneous platform.
Angus Liu Oct 14, 2025 9:40am
Businesswoman ripping up contract

Halozyme pulls Evotec bid after biotech was 'unwilling' to talk

Nov 22, 2024 10:46am
Diverse group of hands holding up US dollar banknotes of various denominations on green background - stock photo

Halozyme offers $2B for Evotec to expand beyond tech used by J&J

Nov 15, 2024 6:01am